This inventor holds 1 USPTO granted patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovator Spotlight: Kimberly Foreman and Her Groundbreaking Cancer Research
Introduction: Kimberly Foreman is an accomplished inventor based in Clarendon Hills, IL, who has made significant strides in the field of cancer research. With her innovative methodologies, she aims to tackle the complexities associated with cancer stem cells and their resistance to treatment.
Latest Patents: Kimberly Foreman holds a patent for her innovative work titled "Targeting cancer stem cells with DR5 agonists." This patent outlines a method for determining the level of resistance or sensitivity of cancer stem cells to a death receptor agonist. The method involves detecting the level of IAP (Inhibitor of Apoptosis Protein) in one or more DR5/DDX3/IAP complexes within or from the cancer stem cells. Additionally, her patent describes a method for killing cancer stem cells within a subject and a strategy for reducing the risk of cancer recurrence in patients.
Career Highlights: Foreman is associated with The UAB Research Foundation, where she contributes her expertise in cancer research. Her innovative approach to understanding cancer stem cells has garnered attention in the medical community, showcasing her commitment to advancing cancer treatment methodologies.
Collaborations: Throughout her career, Kimberly has collaborated with esteemed colleagues such as Donald J. Buchsbaum and Albert F. LoBuglio. These partnerships have fostered a rich environment for scientific inquiry and innovation, furthering the impact of her research on cancer treatment.
Conclusion: Kimberly Foreman stands out as a leading inventor in the realm of cancer research, with her patent providing critical insights into combating cancer stem cell resilience. Her affiliation with The UAB Research Foundation and collaboration with notable researchers highlight her significant contributions to the field. As her work continues to evolve, Foreman's innovative methodologies hold promise for improving patient outcomes in cancer therapy.